Release
📈 Stocks
Bold Therapeutics Presents BOLD-100 Clinical Updates at BIO-Europe
(7 days ago)
Bold Therapeutics updates stakeholders on the clinical advancement of BOLD-100 during the BIO-Europe conference, focusing on its proprietary metallotherapeutics pipeline.